compatability check  |  get technical help
Winnipeg Carcinoid Neuroendocrine Conference
Event Overview



Carcinoid Neuroendocrine cancers are relatively rare malignancies distinguished by small, slow growing tumours which affect the neuro-endocrine system. These tumours typically originate in the gastro-intestinal tract, but sometimes arise in the lungs or other organs.

A variety of excellent treatment options are available, most of which target specific peptide receptors on the tumour cells. Among the best known treatments are Octreotide, Lanreotide and similar hormonal treatments, which provide symptomatic relief and have anti-proliferative benefits. Other newer therapies use these drugs in combination with radioisotopes, as a targeted radiation treatment.

Jim Kormos and Dr John Buscombe moderated the program.

On Saturday 9 May 2009, the Carcinoid Neuroendocrine Tumour Society Canada held a conference at Fort Garry Hotel in Winnipeg, Canada. The theme of the event was "Neuroendocrine Malignancies" and the focus was on emerging modes of treatment. It was a cold and snowy day, but some 70 persons attended, mostly patients and family caregivers.

They were treated to some extraordinary presentations by a panel of Canadian and International physicians. Targeted radiation treatments and their related issues for Canadians were the subject of a special breakfast meeting session.

Various physicians answered questions posed by the audience. Shown here (left to right) are Dr Shereen Ezzat, Dr Richard Baum, Professor Sylvia Esa (seated), Dr Robert Reid and Dr Thomas O'Dorisio.

At the end of the day, there was a spirited audience question and answer session, with many physicians (even those seated within the audience) tackling the questions posed. For those questions which could not be answered during the Q&A session, the physicians replied in writing after the conference.

These recordings were made to share the information more widely.
Recordings



Following are recordings of the various presentations.
  • Introduction and Overview of NETs

    Presenter(s): Maureen Coleman, President, CNETS Canada; Jim Kormos, Vice President, CNETS Canada; Dr Ralph Wong, Medical Oncologist, St Boniface Hospital, Winnipeg, Manitoba
    Duration: 21 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
  • Diagnosis of Gastroenteropancreatic Neuroendocrine Tumours

    Presenter(s): Prof Sylvia Asa, Chief of Pathology University Health Network, Toronto, Ontario; Dr Shereen Ezzat, Endocrine Oncologist, Mt Sinai Hospital, Toronto, Ontario
    Duration: 59 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
  • Treatment of NETs

    Presenter(s): Dr. Thomas O'Dorisio, Endocrinologist, Department of Internal Medicine, University of Iowa
    Duration: 39 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
  • The PROMID Study: Sandostatin Therapy Trial Demonstrates Tumour Regression is Achievable

    Presenter(s): Prof Dr Rudolf Arnold, Department of Internal Medicine, Phillips University, Marburg, Germany
    Duration: 33 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
  • Patients' Insight into Lung Carcinoid Cancer - 3 Case Studies

    Presenter(s): Kathy Arbanasin PhD; Joanne Ferguson, RN, BScN
    Duration: 21 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
  • Surgical Resection of NETS

    Presenter(s): Dr Daryl Gray, Surgical Oncologist, London Health Sciences Centre, London, Ontario
    Duration: 26 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
  • Radionuclide Treatment of NETs - What Patients in the UK Experience

    Presenter(s): Dr John Buscombe, Royal Free Hospital, London, UK
    Duration: 38 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
  • Radiopeptides for Diagnosis (receptor PET/CT) and Therapy (PRRT)

    Presenter(s): Prof Dr Richard Baum, Zentralklinik, Bad Berka, Germany
    Duration: 58 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
  • How to Meet the Needs of a Growing Canadian NET Community

    Presenter(s): Dr Jean-Luc Urbain, President-Canadian Society of Nuclear Medicine, Head of Nuclear Medicine-University of Western Ontario
    Duration: 36 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
  • Audience Question and Answer (followed by official acknowledgements)

    Presenter(s): Physicians' Panel and Maureen Coleman, President, CNETS Canada
    Duration: 1 hour 4 minutes
    View:    broadband video  |  standard video  |  audio (MP3)
About CNETS Canada

The Carcinoid-NeuroEndocrine Tumour Society-Canada (CNETS Canada) was formed in 2007 to assist the Canadian patient and physician community to better understand diagnostic and treatment options for neuroendocrine cancer patients. Carcinoid cancer patients represent over 50% of this neuroendocrine cancer spectrum.

Event Sponsors

Novartis Oncology

Ipsen

Nordion

Lantheus Medical Imaging

Draximage
Photo Credits
Event photos © 2009 by
Silvia Steinhilber,
Treasurer CNETS Canada and
Winnipeg Support Group Leader

Additional photography by Ryan Litovitch
Donate
Podcasts
You can download all the conference MP3 audio files for enjoyment on your iPod or mobile phone. Just copy the link below into iTunes or any similar tool using the 'subscribe to podcast' feature, let the audio files download to your PC's hard disc and then sync them with your mobile device.
   Audio Podcast Listing (RSS)